Chinas Humanoid Robot Push Musk Sees Biggest Competition as Nation Prepares Machines for Workforce JhunjhunwalaPartnered Fund Acquires Stake in Tourism Finance Corporation of India MD Discusses Business Outlook AMD CEO Projects Unprecedented CPU Demand Surge Spanning Five Years Survey Reveals Majority of Retirees Leave Workforce Earlier Than Anticipated Security Incident Near White House May Heighten Market Uncertainty Indian Equity Benchmarks Sensex and Nifty Turn Volatile Hindustan Zinc SBI Force Motors Lead Activity OMER Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Continues ZVRA Q1 2026 Earnings Strong EPS Beat Drives Positive Surprise Yet Stock Slips Slightly Cresud CRESY Q1 2026 Earnings Strong EPS Report Despite Modest Stock Decline ZM Q1 2026 Earnings Strong EPS Beat Amid Revenue Discrepancy Stock Dips ORI Q1 2026 Earnings EPS Misses Estimates by 15 Stock Declines Slightly TTI Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Bright Horizons BFAM Holds Steady Near 67 as Support Level Firms Unum Group UNM Edges Lower as Shares Consolidate Near Support UMH Properties Inc UMH Edges Higher Amid Steady Trading Rush Street Interactive RSI Holds Above Support After Modest Decline Pinterest Stock Gains 3 PINS Tests Key Resistance After Bouncing from Support Swiss Franc and Japanese Yen Strengthen as DeepSeek AI Model Sparks SafeHaven Demand Skye Bioscience Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Biotech Challenges NAPCO Security Technologies NSSC Gains 169 as Stock Tests Key Resistance Champions Oncology Inc CSBR Q1 2026 Earnings Earnings Miss Estimates as EPS Falls to 002 Blackstone Secured Lending Fund BXSL Q1 2026 Earnings EPS Beat Driven by Strong Investment Income and Portfolio Performance QURE Q1 2026 Earnings Narrowed Loss Beats Estimates as Gene Therapy Pipeline Steadies BFAM Q1 2026 Earnings EPS Beat Sends Stock Modestly Higher Revenue Details Unclear VEON Q1 2026 Earnings EPS Beats Estimates Amid Operational Progress DIN Q1 2026 Earnings EPS Surpasses Estimates by 529 Incannex Healthcare IXHL Q1 2026 Earnings Deepening Losses as ClinicalStage Biotech Continues PreRevenue Development